Patients and methods: Retrospective description with longitudinal follow-up on 62 patients diagnosed with stage I, II breast cancer underwent total mastectomy or conservative surgery with adjuvant chemotherapy regimens of Docetaxel plus Cyclophosphamide at National Cancer Hospital from September 2015 to December 2020.